Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00970957
What this trial is testing

Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 107
Not applicableStudy completedNCT00393692
What this trial is testing

Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy

Who this might be right for
Age-related Macular Degeneration
University Hospital, Bonn 700
Testing effectiveness (Phase 2)Study completedNCT01414153
What this trial is testing

Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Lpath, Inc. 158
Testing effectiveness (Phase 2)Study completedNCT03626636
What this trial is testing

A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration

Who this might be right for
Dry Age-related Macular Degeneration
Allegro Ophthalmics, LLC 42
Not applicableStudy completedNCT04779398
What this trial is testing

Association of MPOD Values With Blue Light.

Who this might be right for
Age Related Macular Degeneration
The University of Queensland 96
Not applicableStudy completedNCT00734487
What this trial is testing

AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study

Who this might be right for
Age Related Macular Degeneration
Duke University 470
Not applicableLooking for participantsNCT04796545
What this trial is testing

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

Who this might be right for
AMDAge-Related Macular Degeneration
VisionCare, Inc. 76
Not applicableUnknownNCT05209971
What this trial is testing

Macular Thickness and Visual Acuity in Diabetic Hypertensive Patients

Who this might be right for
Macular Edema
Sohag University 100
Not applicableStudy completedNCT05100511
What this trial is testing

Fundus Image-guided Focal Electroretinography, Usability Study

Who this might be right for
HealthyMacular EdemaMacular Degeneration
Maculaser Oy 20
Testing effectiveness (Phase 2)Study completedNCT01968239
What this trial is testing

Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT

Who this might be right for
Branch Retinal Vein Occlusion
University of Leipzig 27
Not applicableLooking for participantsNCT07308639
What this trial is testing

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)
Bayer 50,000
Not applicableEnded earlyNCT04935411
What this trial is testing

Russian Registry of Patients With nAMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 2,665
Early research (Phase 1)Study completedNCT04989699
What this trial is testing

Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Ocular Therapeutix, Inc. 21
Not applicableStudy completedNCT04857099
What this trial is testing

Impact of the Navilas ® Micropulse Laser Treatment for Macular Edema Within the CHU Brugmann Hospital Macular Edema

Who this might be right for
Macular Edema
Brugmann University Hospital 23
Early research (Phase 1)Study completedNCT00414999
What this trial is testing

Safety Study of TG100801 Eye Drops in Healthy Volunteers

Who this might be right for
Macular DegenerationDiabetic Retinopathy
TargeGen 44
Not applicableStudy completedNCT03803631
What this trial is testing

CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)

Who this might be right for
AMDExudative Macular Degeneration
Centre Hospitalier Intercommunal Creteil 49
Not applicableStudy completedNCT01728883
What this trial is testing

Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study

Who this might be right for
Diabetic RetinopathyDiabetic Macular Edema
Vital Art and Science Incorporated 60
Not applicableStudy completedNCT02181530
What this trial is testing

Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 43
Post-approval studies (Phase 4)Study completedNCT01277302
What this trial is testing

A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

Who this might be right for
Macular Edema
Genentech, Inc. 202
Testing effectiveness (Phase 2)Ended earlyNCT00089830
What this trial is testing

A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Genaera Corporation 120
Next Page